GH · Guardant Health Inc
United States · RS rating 87 · As of 2026-10-14
| Price | 162.99 USD |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 87 / 30 / 80 / 97 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 41 / 49 / 31 |
| Industry group (rank) | Medical-Services (44) |
| EPS growth Q/Q | -35.1% |
| Sales growth Q/Q | +6.1% |
| Distance from 52-week high | +12.9% |
| Market cap (USD) | $11.5B |